MAP2K3 and colorectal carcinoma: Therefore, this study delineates a previously unrecognized ubiquitin-dependent regulatory mechanism for MKK3-p38/MAPK signaling and highlights the considerable therapeutic potential of combinatorial targeting of this pathway in CRC.